Carl Zeiss Total Debt vs. Current Valuation
| CZMWY Stock | USD 60.09 1.76 3.02% |
For Carl Zeiss profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Carl Zeiss to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Carl Zeiss Meditec utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Carl Zeiss's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Carl Zeiss Meditec over time as well as its relative position and ranking within its peers.
Carl |
Carl Zeiss Meditec Current Valuation vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Carl Zeiss's current stock value. Our valuation model uses many indicators to compare Carl Zeiss value to that of its competitors to determine the firm's financial worth. Carl Zeiss Meditec is rated below average in total debt category among its peers. It also is rated below average in current valuation category among its peers reporting about 100.51 of Current Valuation per Total Debt. Comparative valuation analysis is a catch-all model that can be used if you cannot value Carl Zeiss by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Carl Zeiss' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Carl Total Debt vs. Competition
Carl Zeiss Meditec is rated below average in total debt category among its peers. Total debt of Medical Instruments & Supplies industry is currently estimated at about 83.45 Billion. Carl Zeiss adds roughly 120.05 Million in total debt claiming only tiny portion of all equities under Medical Instruments & Supplies industry.
Carl Current Valuation vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Carl Zeiss |
| = | 120.05 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Carl Zeiss |
| = | 12.07 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Carl Current Valuation vs Competition
Carl Zeiss Meditec is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Medical Instruments & Supplies industry is currently estimated at about 328.1 Billion. Carl Zeiss holds roughly 12.07 Billion in current valuation claiming about 4% of all equities under Medical Instruments & Supplies industry.
Carl Zeiss Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Carl Zeiss, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Carl Zeiss will eventually generate negative long term returns. The profitability progress is the general direction of Carl Zeiss' change in net profit over the period of time. It can combine multiple indicators of Carl Zeiss, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 3531 people.
Carl Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Carl Zeiss. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Carl Zeiss position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Carl Zeiss' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Carl Zeiss without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Use Investing Themes to Complement your Carl Zeiss position
In addition to having Carl Zeiss in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Military Industrial Thematic Idea Now
Military Industrial
A collection of large United States defense contractors including companies involved in production or distribution of aircraft, ships, vehicles, weaponry, and electronic systems in cooperation with the government. The Military Industrial theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Military Industrial Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Carl Pink Sheet Analysis
When running Carl Zeiss' price analysis, check to measure Carl Zeiss' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carl Zeiss is operating at the current time. Most of Carl Zeiss' value examination focuses on studying past and present price action to predict the probability of Carl Zeiss' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carl Zeiss' price. Additionally, you may evaluate how the addition of Carl Zeiss to your portfolios can decrease your overall portfolio volatility.